Table 3 Cumulative incidence of targeted events during the 5-year follow-up
Treatment | Control group 1 Screened candidate | Control group 2 Beneficiary within inclusion criteria | |
|---|---|---|---|
Diabetes-related complications (all) | 12.9% | 13.3% | 20.4%* |
Ischemic heart disease | 3.6% | 2.9% | 2.2% |
Stroke | 0.7% | 1.5% | 3.1% |
Retinopathy requiring surgery | 4.3% | 5.1% | 6.3% |
Neuropathy | 3.6% | 1.5% | 2.4% |
End-stage renal disease requiring dialysis | 0.7% | 1.2% | 4.3%* |
Intensive care use | 5.0% | 5.3% | 8.4% |
Emergency care use | 15.1% | 18.4% | 25.5%** |
All-cause hospitalization | 51.8% | 56.1% | 59.4% |
Dependency in activities of daily living | 2.2% | 2.7% | 4.3% |
All-cause mortality | 3.6% | 2.9% | 2.2% |